// App-Quantinova.ai

: Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

Researchers

Presenter

  • Laurence Legros

Principal Investigators

  • Dana Ranta

  • Lydia Roy

  • Mario Ojeda-Uribe

  • Stephane Giraudier

  • Nathalie Parquet

  • Jean Christophe Ianotto

  • Mathieu Wemeau

  • Isabelle Plantier

  • Franck E. Nicolini

  • Eric Lippert

  • Pascale Cony-Makhoul

  • Fiorenza Barraco

  • Laure Stalnikiewicz

  • Frederic Garban

  • Brigitte Dupriez

  • Francois Girodon

  • Anne Brignier

  • Yazid Arkam

  • Mathieu Meunier

  • Chloe James

  • Valérie Rolland-Neyret

  • Valerie Ugo

  • Pierre Morel

  • Marie C Bene

  • Jean-Jacques Kiladjian

Medical Centers

  • Hematology Biology, Angers University Hospital, Angers, France

  • Service d'hématologie, GHR Mulhouse Sud Alsace, mulhouse, France

  • Service des maladies du sang, Centre Hospitalier Universitaire d'Angers, Angers, France

  • France Intergroupe des Néoplasies Myéloprolifératives, FIM collaborative group, Paris, France

  • Department of Hematology, CHU Grenoble Alpes, Grenoble, France

  • Hematology department, Hopital Henri Mondor, Creteil, France

  • French Intergroup of Myeloproliferative neoplasms, FIM collaborative group, Paris, France

  • Department of Hematology, CHU de Brest, Brest, FRA

  • FIM, paris, France

  • Hematology department & CRCL, Centre Léon Bérard, Lyon, France

  • Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France

  • Université de Paris, Cellular biology Department, Saint-Louis hospital, APHP, Paris, France

  • Unite INSERM U, Pessac, FRA

  • INSERM UMR , Saint-Louis Research Institute, Paris, France

  • Service d'hématologie clinique, CH Roubaix, Roubaix, France

  • Centre d'Investigations Cliniques, Hôpital Saint-Louis, Paris, France

  • Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens, Salouel, France

  • Department of Hematology and Cellular Therapy, GHRMSA, Mulhouse, France

  • Therapeutic Apheresis Unit, Saint Louis Hospital, Paris, France

  • Centre Hospitalier Universitaire, Nancy, France

  • CHR de Roubaix, Roubaix, FRA

  • Department of Hematology, CHU de Grenoble, La Tronche, FRA

  • Department of Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France

  • CHU de Grenoble, Grenoble, France

  • Centre hospitalier Lens, lens, French Southern Territories

  • Department of clinical Hematology, APHP-Université Paris Saclay-Hôpital Bicêtre, Kremlin-Bicêtre, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Hematological malignancies

  • Acute respiratory failure

  • Pulmonary arterial hypertension

  • Hypertension

  • Venous thrombosis

  • Coronavirus disease

  • Stroke

  • Myeloid neoplasms

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Calreticulin

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Ruxolitinib phosphate

  • Anagrelide hydrochloride

  • Interferon

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

  • Cohort

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved